The ROE as of November 2024 (TTM) for Achieve Life Sciences, Inc. (ACHV) is -116.78%

According to Achieve Life Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -116.78%. This represents a change of -376.38% compared to the average of 42.25% of the last 4 quarters.

Achieve Life Sciences, Inc. (ACHV) Historical ROE (quarterly & annually)

How has ACHV ROE performed in the past?

The mean historical ROE of Achieve Life Sciences, Inc. over the last ten years is 86.60%. The current -116.78% ROE has changed -234.85% with respect to the historical average. Over the past ten years (40 quarters), ACHV's ROE was at its highest in in the December 2023 quarter at 378.18%. The ROE was at its lowest in in the March 2023 quarter at -2159.14%.

Achieve Life Sciences, Inc. (ACHV) ROE by Quarter and Year

Discovering the peaks and valleys of Achieve Life Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Achieve Life Sciences, Inc. (ACHV) Average ROE

How has ACHV ROE performed in the past?

The current ROE of Achieve Life Sciences, Inc. (ACHV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Achieve Life Sciences, Inc. (ACHV) ROE vs. Peers

How is ACHV’s ROE compared to its peers?

Achieve Life Sciences, Inc.’s ROE is greater than VectivBio Holding AG (-56.92%), greater than Icosavax, Inc. (-41.24%), greater than Apellis Pharmaceuticals, Inc. (-139.02%), greater than iTeos Therapeutics, Inc. (-18.19%), greater than TScan Therapeutics, Inc. (-59.83%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Immix Biopharma, Inc. (-86.48%), less than CNS Pharmaceuticals, Inc. (428.91%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), greater than Freeline Therapeutics Holdings plc (-110.68%), less than AVROBIO, Inc. (29.68%), greater than NextCure, Inc. (-57.63%), greater than CytomX Therapeutics, Inc. (-27.44%), greater than Neoleukin Therapeutics, Inc. (-47.64%), less than Spero Therapeutics, Inc. (20.70%), greater than Assembly Biosciences, Inc. (-121.55%), greater than Bolt Biotherapeutics, Inc. (-61.40%), less than Coherus BioSciences, Inc. (23.81%), greater than Gracell Biotechnologies Inc. (-37.20%),

Build a custom stock screener for Achieve Life Sciences, Inc. (ACHV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achieve Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achieve Life Sciences, Inc. (ACHV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achieve Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.